Cargando…
Pharmacokinetics of UGN-101, a mitomycin-containing reverse thermal gel instilled via retrograde catheter for the treatment of low-grade upper tract urothelial carcinoma
PURPOSE: To evaluate the pharmacokinetic properties of UGN-101, a mitomycin-containing reverse thermal gel used as primary chemoablative treatment for low-grade upper tract urothelial carcinoma (UTUC), in a subset of patients participating in a phase 3 clinical trial. METHODS: Pharmacokinetic parame...
Autores principales: | Shabsigh, Ahmad, Kleinmann, Nir, Smith, Angela B., Scherr, Douglas, Seltzer, Elyse, Schoenberg, Mark, Lerner, Seth P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8110485/ https://www.ncbi.nlm.nih.gov/pubmed/33677615 http://dx.doi.org/10.1007/s00280-021-04246-w |
Ejemplares similares
-
UGN-101 (mitomycin gel): a novel treatment for low-grade upper tract
urothelial carcinoma
por: Kokorovic, Andrea, et al.
Publicado: (2020) -
Primary Chemoablation of Low-Grade Intermediate-Risk Nonmuscle-Invasive Bladder Cancer Using UGN-102, a Mitomycin-Containing Reverse Thermal Gel (Optima II): A Phase 2b, Open-Label, Single-Arm Trial
por: Chevli, K. Kent, et al.
Publicado: (2022) -
Effectiveness of an Immediate Mitomycin C Instillation in Patients with Superficial Bladder Cancer Receiving Periodic Mitomycin C Instillation
por: Jung, Seok Jin, et al.
Publicado: (2011) -
Efficacy of instillation of MB49 cells and thermoreversible polymeric gel in urothelial bladder carcinoma immunization
por: Santana, Jhonne Pedro Pedott, et al.
Publicado: (2022) -
Intravesical Instillation of Mitomycin C: A Cause of Delayed Bladder Perforation?
por: Penna, Marta, et al.
Publicado: (2012)